Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma.
Melaiu O, Mina M, Chierici M, Boldrini R, Jurman G, Romania P, D'Alicandro V, Benedetti MC, Castellano A, Liu T, Furlanello C, Locatelli F, Fruci D. Melaiu O, et al. Among authors: furlanello c. Clin Cancer Res. 2017 Aug 1;23(15):4462-4472. doi: 10.1158/1078-0432.CCR-16-2601. Epub 2017 Mar 7. Clin Cancer Res. 2017. PMID: 28270499
Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors.
Boldrini R, De Pasquale MD, Melaiu O, Chierici M, Jurman G, Benedetti MC, Salfi NC, Castellano A, Collini P, Furlanello C, Pistoia V, Cifaldi L, Terenziani M, Fruci D. Boldrini R, et al. Among authors: furlanello c. Oncoimmunology. 2018 Dec 13;8(2):e1542245. doi: 10.1080/2162402X.2018.1542245. eCollection 2019. Oncoimmunology. 2018. PMID: 30713803 Free PMC article.
Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.
Gnani D, Romito I, Artuso S, Chierici M, De Stefanis C, Panera N, Crudele A, Ceccarelli S, Carcarino E, D'Oria V, Porru M, Giorda E, Ferrari K, Miele L, Villa E, Balsano C, Pasini D, Furlanello C, Locatelli F, Nobili V, Rota R, Leonetti C, Alisi A. Gnani D, et al. Among authors: furlanello c. Cell Death Differ. 2017 May;24(5):889-902. doi: 10.1038/cdd.2017.34. Epub 2017 Mar 24. Cell Death Differ. 2017. PMID: 28338656 Free PMC article.
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
Ceccarelli S, Panera N, Mina M, Gnani D, De Stefanis C, Crudele A, Rychlicki C, Petrini S, Bruscalupi G, Agostinelli L, Stronati L, Cucchiara S, Musso G, Furlanello C, Svegliati-Baroni G, Nobili V, Alisi A. Ceccarelli S, et al. Among authors: furlanello c. Oncotarget. 2015 Dec 8;6(39):41434-52. doi: 10.18632/oncotarget.5163. Oncotarget. 2015. PMID: 26573228 Free PMC article.
Promoter-level expression clustering identifies time development of transcriptional regulatory cascades initiated by ErbB receptors in breast cancer cells.
Mina M, Magi S, Jurman G, Itoh M, Kawaji H, Lassmann T, Arner E, Forrest ARR, Carninci P, Hayashizaki Y, Daub CO; FANTOM Consortium; Okada-Hatakeyama M, Furlanello C. Mina M, et al. Among authors: furlanello c. Sci Rep. 2015 Jul 16;5:11999. doi: 10.1038/srep11999. Sci Rep. 2015. PMID: 26179713 Free PMC article.
Multi-omics integration for neuroblastoma clinical endpoint prediction.
Francescatto M, Chierici M, Rezvan Dezfooli S, Zandonà A, Jurman G, Furlanello C. Francescatto M, et al. Among authors: furlanello c. Biol Direct. 2018 Apr 3;13(1):5. doi: 10.1186/s13062-018-0207-8. Biol Direct. 2018. PMID: 29615097 Free PMC article.
Identification of GALNT14 as a novel neuroblastoma predisposition gene.
De Mariano M, Gallesio R, Chierici M, Furlanello C, Conte M, Garaventa A, Croce M, Ferrini S, Tonini GP, Longo L. De Mariano M, et al. Among authors: furlanello c. Oncotarget. 2015 Sep 22;6(28):26335-46. doi: 10.18632/oncotarget.4501. Oncotarget. 2015. PMID: 26309160 Free PMC article.
93 results